COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 1358: Articles 13571-13580  | Next

Comparison of Mental Health Symptom Changes from pre-COVID-19 to COVID-19 by Sex or Gender: A Systematic Review and Meta-analysis
Dal Santo, T., Sun, Y., Wu, Y., He, C., Wang, Y., Jiang, X., Li, K., Bonardi, O., Krishnan, A., Boruff, J. T., Rice, D. B., Markham, S., Levis, B., Azar, M., Neupane, D., Tasleem, A., Yao, A., Thombs-Vite, I., Agic, B., Fahim, C., Martin, M. S., Sockalingam, S., Turecki, G., Benedetti, A., Thombs, B. B.
10.1101/2021.06.28.21259384 — Posted: 2021-07-02
Use of the Elimination Strategy in Response to the COVID-19 Pandemic: Health and Economic Impacts for New Zealand Relative to Other OECD Countries
Wilson, N., Grout, L., Summers, J. A., Nghiem, N., Baker, M. G.
10.1101/2021.06.25.21259556 — Posted: 2021-07-02
An immune-protein signature combining TRAIL, IP-10 and CRP for accurate prediction of severe COVID-19 outcome
Samuel Mastboim, N., Angel, A., Shaham, O., Ilan Ber, T., Navon, R., Simon, E., Rosenberg, M., Israeli, Y., Hainrichson, M., Avni, N., Reiner, E., Feigin, P., Oved, K., Tadmor, B., Singer, P., Kagan, I., Lev, S., Diker, D., Jarjoui, A., Kurd, R., Ben-Chetrit, E., Danziger, G., Papan, C., Motov, S., Shapira, M., Stein, M., Klein, A., Gottlieb, T. M., Eden, E.
10.1101/2021.06.27.21259196 — Posted: 2021-07-02
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Coggins, S. A., Laing, E. D., Olsen, C. H., Goguet, E., Moser, M., Jackson-Thompson, B. M., Samuels, E. C., Pollett, S. D., Tribble, D. R., Davies, J., Illinik, L., Hollis-Perry, M., Maiolatesi, S. E., Duplessis, C. A., Ramsey, K. F., Reyes, A. E., Alcorta, Y., Wong, M. A., Wang, G., Ortega, O., Parmelee, E., Lindrose, A. R., Snow, A. L., Malloy, A. M., Letizia, A. G., Powers, J. H., Burgess, T. H., Broder, C. C., Mitre, E.
10.1101/2021.06.25.21259544 — Posted: 2021-07-02 Discussion: Offsite
Self-assessment of COVID-19 vaccination efficacy using a simple POCT for SARS-CoV-2 S1 protein antibody IgG-IgM
Li, M., Shan, Y., Cai, K., Ren, W., Sun, H., Wu, S., Li, J., Hong, D., Zhang, Z., Wang, Q., Qin, L., Sun, Y., Ye, C., Jiang, H., Wang, Z., Jiang, Y., Liu, C., Hu, B., Chen, R., Sun, L.
10.1101/2021.06.27.21258591 — Posted: 2021-07-02
A Retrospective analysis of DIC score and SIC score in prediction of COVID-19 severity
Kapoor, M., Panda, P. K., Saini, L. K., Bahurupi, Y. A.
10.1101/2021.06.26.21259369 — Posted: 2021-07-02
Communicating about COVID-19 vaccine development and safety
Thorpe, A., Fagerlin, A., Butler, J., Stevens, V., Drews, F. A., Shoemaker, H., Riddoch, M. S., Scherer, L. D.
10.1101/2021.06.25.21259519 — Posted: 2021-07-02
COVID-19 Flow-Maps: An open geographic information system on COVID-19 and human mobility for Spain
Ponce de Leon, M., del Valle, J., Fernandez, J. M., Bernardo, M., Cirillo, D., Sanchez-Valle, J., Smith, M., Capella-Gutierrez, S., Gullon, T., Valencia, A.
10.1101/2021.06.23.21259395 — Posted: 2021-07-02
COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
Emes, D. T., Hüls, A., Baumer, N., Dierssen, M., Puri, S., Russel, L., Sherman, S. L., Strydom, A., Bargagna, S., Brandao, A. C., Costa, A. C. S., Chicoine, B. A., Ghosh, S., Rebillat, A.-S., Sgandurra, G., Valentini, D., Rohrer, T. R., Levin, J., Lakhanpaul, M.
10.1101/2021.06.25.21259525 — Posted: 2021-07-02
Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria; a retrospective cohort study.
de la Court, J. R., Coenen, S., Buis, D. T. P., Meijboom, L. J., Schade, R. P., Visser, C. E., van Hest, R. M., Kuijvenhoven, M., Prins, J. M., Nijman, S. F. M., Sieswerda, E., Sigaloff, K. C. E.
10.1101/2021.06.23.21259020 — Posted: 2021-07-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).